https://artiambio.net/
Type 1 cannabinoid receptor (CB1) antagonists | Artiam Bio
Jun 5, 2024 - Artiam Bio, Inc. is a biotechnology company developing refined type 1 cannabinoid receptor (CB1) antagonists to treat significant diseases.
cannabinoid receptortypeantagonistsbio